title: Diaphyseal femoral fatigue fracture associated with bisphosphonate therapy - 3 more cases.
authors.affiliation: Department of Orthopaedic Surgery, Asahi General Hospital, Japan.
authors.forename: Kaiya
authors.initials: K
authors.lastname: Osugi
authors.forename: Shigeki
authors.initials: S
authors.lastname: Miwa
authors.forename: Shinobu
authors.initials: S
authors.lastname: Marukawa
authors.forename: Kouhei
authors.initials: K
authors.lastname: Marukawa
authors.forename: Yoshiharu
authors.initials: Y
authors.lastname: Kawaguchi
authors.forename: Shinichi
authors.initials: S
authors.lastname: Nakato
mesh_terms: D000368:Aged; D019386:Alendronate / Q000009:adverse effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D012968:Etidronic Acid / Q000009:adverse effects; D005260:Female; D005264:Femoral Fractures / Q000139:chemically induced*; D015775:Fractures, Stress / Q000150:complications*; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy
chemical_list: D050071:Bone Density Conservation Agents; D012968:Etidronic Acid; D019386:Alendronate